CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-05-06 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Option | +18,077 | 316,065 | ||
| 2009-03-16 | FORBES CHRISTOPHER Director | Purchase | +2,300 | $0.46 | $1K | 2,091,521 |
| 2009-03-16 | FORBES CHRISTOPHER Director | Purchase | +2,300 | $0.49 | $1K | 2,093,821 |
| 2009-03-16 | FORBES CHRISTOPHER Director | Purchase | +200 | $0.51 | $102 | 2,094,021 |
| 2009-03-13 | FORBES CHRISTOPHER Director | Purchase | +10,200 | $0.39 | $4K | 2,089,221 |
| 2009-03-12 | FORBES CHRISTOPHER Director | Purchase | +2,000 | $0.36 | $720 | 2,079,021 |
| 2009-03-10 | FORBES CHRISTOPHER Director | Purchase | +2,500 | $0.37 | $925 | 2,077,021 |
| 2009-03-09 | FORBES CHRISTOPHER Director | Purchase | +10,000 | $0.38 | $4K | 2,074,521 |
| 2009-03-05 | FORBES CHRISTOPHER Director | Purchase | +1,000 | $0.40 | $400 | 2,064,521 |
| 2009-03-04 | FORBES CHRISTOPHER Director | Purchase | +5,500 | $0.40 | $2K | 2,061,521 |
| 2009-03-04 | FORBES CHRISTOPHER Director | Purchase | +2,000 | $0.38 | $760 | 2,063,521 |
| 2009-03-03 | FORBES CHRISTOPHER Director | Purchase | +3,000 | $0.39 | $1K | 2,054,821 |
| 2009-03-03 | FORBES CHRISTOPHER Director | Purchase | +1,200 | $0.40 | $480 | 2,056,021 |
| 2009-03-02 | FORBES CHRISTOPHER Director | Purchase | +2,800 | $0.37 | $1K | 2,051,821 |
| 2009-02-27 | FORBES CHRISTOPHER Director | Purchase | +3,000 | $0.40 | $1K | 2,047,021 |
| 2009-02-27 | FORBES CHRISTOPHER Director | Purchase | +2,000 | $0.39 | $780 | 2,049,021 |
| 2009-02-26 | FORBES CHRISTOPHER Director | Purchase | +4,000 | $0.40 | $2K | 2,044,021 |
| 2009-02-20 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Option | +23,404 | 337,988 | ||
| 2009-02-19 | FORBES CHRISTOPHER Director | Purchase | +882,381 | 3,044,180 |
Page 3 of 3 · 59 trades